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Genome sequencing data for Streptococcus equi subspecies equi and zooepidemicus were used to develop a
novel diagnostic triplex quantitative PCR (qPCR) assay targeting two genes speciﬁc to S. equi (eqbE and
SEQ2190) and a unique 100 base pair control DNA sequence (SZIC) inserted into the SZO07770 pseudogene
of S. zooepidemicus strain H70. This triplex strangles qPCR assay can provide results within 2 h of sample
receipt, has an overall sensitivity of 93.9% and speciﬁcity of 96.6% relative to the eqbE singlex assay and
detects S. equi at levels below the threshold of the culture assay, even in the presence of contaminating
bacteria.
 2012 Elsevier Ltd. Open access under CC BY license.Introduction
Strangles, caused by Streptococcus equi subspecies equi, is the
most frequently diagnosed infectious disease of horses worldwide
and is responsible for signiﬁcant welfare concerns and economic
losses to the equine industry. The disease is characterised by
abscessation of the lymph nodes of the head and neck. Abscesses
formed in the retropharyngeal lymph nodes usually rupture into
the guttural pouches, which drain via the nostrils, leading to the
classical mucopurulent nasal discharge associated with strangles.
Over time, the purulent material in the guttural pouches of some
horses becomes inspissated, enabling S. equi to persist in horses
that have recovered from the acute disease for up to several years
in the absence of clinical signs (Newton et al., 1997).
S. equi is shed from persistently infected carrier horses periodi-
cally, allowing transmission to naïve individuals and resulting in
new outbreaks of disease. The generation and persistence of carri-
ers within equine populations is critical to the spread of S. equi
infection. Efﬁcient identiﬁcation and treatment of carriers is
important for prevention and eradication of this disease.
Diagnosis of S. equi infection has been based upon the culture of
this b-haemolytic organism using selective media, followed by
biochemical tests, which rely on the inability of S. equi to ferment
trehalose, lactose or sorbitol (Bannister et al., 1985). Isolation of
b-haemolytic colonies may be confounded by the presence of other
bacteria, most notably Streptococcus equi subspecies zooepidemicus
and Streptococcus dysgalactiae subspecies equisimilis, which may42.
aller).
cense.lead to the generation of false negative results. Isolation and
identiﬁcation of S. equi by routine methods is time consuming
and requires a minimum of 48 h from receipt of clinical samples.
This reporting delay often has consequences for the isolation of in-
fected horses, providing S. equi with greater opportunity to trans-
mit through naïve populations.
The ﬁrst PCR-based test developed for S. equi targeted the 50 re-
gion of the SeM gene. Using this target, up to three times more clin-
ical samples were positive for S. equi than by culture and
biochemical tests alone (Timoney and Artiushin, 1997; Newton
et al., 2000). Historically, the SeM gene was thought to be non-var-
iant, based upon its HindIII restriction pattern on Southern blotting
(Galan and Timoney, 1988). However, it is now known that this re-
gion of the SeM gene is highly variable (Anzai et al., 2005; Kelly
et al., 2006) and can be deleted in strains of S. equi isolated from
persistently infected carriers (Chanter et al., 2000). The loss of
diagnostic PCR targets leading to incorrect reporting can have del-
eterious consequences for the control of infectious disease. In Swe-
den, the occurrence of a 377 base pair (bp) deletion in CDS1 of the
pSW2 plasmid of the human pathogen Chlamydia trachomatis re-
sulted in the false negative diagnosis of many infected patients,
and the rapid spread of this variant within the population
(Seth-Smith et al., 2009).
Genes for the superantigens seeH, seeI, seeL and seem, encoded
on the prophages uSeq4 and uSeq3, have potential as diagnostic
candidates for S. equi subsp. equi (Baverud et al., 2007). However,
the production of four superantigens confers a certain level of
functional redundancy that could lead to loss of target sequences
(Paillot et al., 2010). Furthermore, S. zooepidemicus multilocus se-
quence types ST-106, ST-118 and ST-120 were qPCR positive for
seeL and seeM (Holden et al., 2009), suggesting that the use of these
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some S. zooepidemicus strains. The gene encoding the factor
H-binding protein Se18.9 has also been highlighted as a diagnostic
target, but is present in ST-57 strains of S. zooepidemicus (Holden
et al., 2009), suggesting that qPCRs targeting this sequence may
also lead to false positive results.
To ensure the robust and sensitive identiﬁcation of horses in-
fected with S. equi, we have developed a triplex qPCR test that tar-
gets two S. equi-speciﬁc genes and employs an internal control
strain of S. zooepidemicus, which serves as a DNA extraction and
within-assay PCR control for every sample to reduce the risk of
false negative reporting.Materials and methods
Bacterial strains, media and growth conditions
S. equi strain 4047 (Se4047) was isolated from a submandibular lymph node ab-
scess of a New Forest pony in 1990 and S. zooepidemicus strain H70 (SzH70) was iso-
lated from a Thoroughbred horse in 2000. Strains were cultured in Todd Hewett
broth (Oxoid) at 37 C with 5% CO2.
Target selection
S. equi-speciﬁc targets were selected by use of comparative genome analysis of
the published Se4047 and SzH70 genomes (Heather et al., 2008; Holden et al., 2009).
eqbE and SEQ2190 were ampliﬁed by PCR using DNA samples previously extracted
from 26 S. equi strains (Holden et al., 2009) and the primers ZM435/ZM436 and
2190A/2190B, respectively (Table 1). Products were sequenced on an ABI3100
DNA sequencer with BigDye ﬂuorescent terminators using the same primers, with
the addition of ZM437 for sequencing eqbE.
Design and generation of the Sz07770c internal control strain
Two 500 bp fragments of the SZO07770 pseudogene were ampliﬁed by PCR from
SzH70 using primers Ec07770Fwd1/Ec07770Rev1a and Ec07770Fwd2/
Ec07770Rev2 (Table 1). PCR products were digested with EcoR1/Pvu1 and Pvu1/
Sal1, respectively, and ligated into the multiple cloning site of the pGHost9 plasmid
to generate pGHost9DSZO07770, which was sequenced using primers 50pGhost9
and 30pGhost9 (Table 1).
An artiﬁcial 82 bp DNA sequence with no signiﬁcant homology with any nucle-
otide sequences on the NCBI database was designed (Table 1). Restriction sites for
PvuI and AgeI were engineered to the 50 and 30 end of this DNA fragment, respec-
tively, and the resultant DNA sequence, SZIC, was produced using the Gene Oracle
gene synthesis service. The synthesised SZIC DNA was digested with PvuI and AgeITable 1
Primer and probe sequences.
Primer/probe name Sequence (50–30)a
ZM435 CCGAATTTGTCCAAGTGGTATG
ZM436 GCACTCCGTTATACTCACTG
ZM437 TTTGCTAGTGCTACTCCTGC
2190A ATGGGAACAGGACTACTTG
2190B GTCTTAGCTTCCTCTTTCGC
Ec07770Fwd1 GACGACGAATTCTGAGAGGCAAGTGACGAGTC
Ec07770Rev1a GACGACCGATCGGACGACACCGGTTTGCCAAACTCCCTTCCAA
Ec07770Fwd2 GACGACCGATCGCACTTGCTTGTTCTAGCTGAG
Ec07770Rev2 GACGACGTCGACGGAACGAACCTCTTACCACA
50pGhost9 TTGGAAAGTTACACGTTACTAAAG
30pGhost9 GGGCGAATTGGGGTACCGGGC
eqbE2 forward TGGGATTCTGTGCCGATTTT
eqbE2 reverse CCCTGAAAGCATCACAATTCTAAA
2190 forward CAACGCGTAGAAGAACGATCTAAA
2190 reverse CCTCCAATTGAGCTTTTTGGTT
SZIC forward CGCATGCGGGTAGATTATGTAG
SZIC reverse TCCCACGAGAAGGTCGAGAA
eqbE2 probe ATTGTTACTATGGCTGAAGGT
2190 probe AAGCCAAGGAAGCCACT
SZIC probe AGAGACATCCAGGTCAA
Artiﬁcial 82 bp DNA
sequence
CCGTGTATTACGCATGCGGGTAGATTATGTAGGTAGAGACATC
a Restriction sites are underlined.restriction enzymes and sub-cloned into pGHost9DSZO07770 digested with the
same restriction enzymes, such that the resultant plasmid, pGHost9SZIC, contained
SZIC ﬂanked by 500 bp SZO07770 gene fragments.
The pGHost9SZIC plasmid was transformed into electro-competent SzH70. Inte-
gration of the construct, inserting the SZIC sequence into the chromosomal copy of
the SZO07770 gene and excision of the pGHost9 plasmid, was achieved by allelic
replacement mutagenesis, as described for a DprtM mutant (Hamilton et al.,
2006), creating the strain Sz07770c. The ﬁdelity of SZIC was conﬁrmed by PCR
and sequencing across the SZO07770 insertion site.
The Sz07770c strain was grown to an optical density of 0.3 at 600 nm in Todd
Hewitt Broth and inactivated by heating at 95 C for 30 min. No colonies of
Sz07770c were obtained when 100 lL of this culture was incubated overnight at
37 C in 5% CO2 on colistin-oxolinic acid blood agar (COBA) streptococcal selective
agar (Oxoid). The killed culture was diluted to obtain a bacterial density equivalent
to 80,000 colony-forming units (cfu)/mL in phosphate buffered saline and stored at
20 C prior to use.
DNA extraction for assay validation
One millilitre of excess clinical sample was spiked with 25 lL killed diluted
Sz07770c, containing bacteria equivalent to 2000 cfu in the original live culture.
DNA was extracted using the GenElute kit (Sigma) and eluted in 200 lL double dis-
tilled H2O.
Development of the triplex qPCR assay
Compatible primers and minor groove binder (MGB) probes were designed
against eqbE, SEQ2190 and SZIC (Table 1). Reaction conditions were optimised for
a fast cycling assay using an ABI StepOne Plus instrument using KAPA Fast probe
mix (Kapa Biosystems) in a ratio of 50:50 master mix:DNA sample. Each reaction
contained 10 lL KAPA Fast probe mix, 450 nM eqbE2 forward, 450 nM eqbE2 re-
verse, 450 nM 2190 forward, 450 nM 2190 reverse, 200 nM SZIC forward, 200 nM
SZIC reverse, 150 nM eqbE2 probe, 2190 probe and SZIC probe and 10 lL DNA ex-
tracted from the clinical sample. Thermal cycling conditions were 3 min at 95 C,
followed by 40 cycles of 95 C for 3 s and 60 C for 10 s. All qPCR experiments were
performed in triplicate.
Validation of the triplex qPCR assay and comparison with the eqbE singlex qPCR assay
Clinical samples (n = 213; >2 mL) received by the Animal Health Trust (AHT)
diagnostic laboratories for detection of S. equi via the eqbE singlex qPCR assay were
used in this study (see Appendix A: Supplementary Table 1). Two 1 mL aliquots of
the original clinical sample were removed and blinded. Heat-killed Sz07770c
(25 lL) was added to one aliquot and both aliquots were then centrifuged at
16,100 g. DNA was isolated from the pellets using the GenElute kit (Sigma). Samples
containing spiked Sz07770c were analysed using the triplex qPCR assay and the
number of copies of eqbE in the DNA isolated from the other aliquot was quantiﬁed
by qPCR using the eqbE singlex assay by the AHT diagnostic laboratory.Label/restriction site
EcoRI
G PvuI, AgeI
PvuI
SalI
FAM
VIC
NED
CAGGTCAAGTTCTCGACCTTCTCGTGGGAGGTGAACCAG
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Clinical samples (n = 194) submitted to the AHT diagnostic laboratory were
tested for S. equi by routine culture and identiﬁcation.
Statistical analysis
Receiver operator characteristic (ROC) curves, sensitivity and speciﬁcity of the
qPCR and culture assays were calculated using STATA (StataCorp LP). Two-tailed
Spearman’s Coefﬁcients were calculated using PASW (version 18, SPSS). A two-
tailed unpaired student’s t test was used to determine the signiﬁcance of continu-
ous data.
Results
Conservation of eqbE and SEQ2190 targets
PCR and sequencing of a 1063 bp region of eqbE (positions
1,229,518 to 1,228,456 of the Se4047 genome) and a 449 bp region
of SEQ2190 (positions 2,203,349 to 2,203,797 of the Se4047 gen-
ome) demonstrated that these sequences were identical across
all 26 strains of S. equi examined.
Generation of the Sz07770c strain
PCR and sequencing across the insertion site conﬁrmed that the
SZIC sequence had been incorporated into the SZO07770 pseudo-
gene in the Sz07770c strain and that all plasmid DNA had been
excised.
Limit of detection of the triplex qPCR assay
Quantiﬁcation of eqbE, SEQ2190 and SZIC in samples containing
a dilution series of Se4047 DNA and approximately 2000 copies of
DNA from Sz07770c determined that the triplex qPCR assays had a
limit of detection of 20 copies (eqbE assay) and 10 copies (SEQ2190
assay) of S. equi DNA, respectively (Fig. 1). Increasing the quantities
of Se4047 DNA above 10,000 copies led to competition and inhibi-
tion of the SZIC assay (Fig. 1).
Validation of the triplex qPCR assay
Sixty-six of 213 clinical samples tested positive for S. equi via
the eqbE singlex qPCR assay (eqbE copy number P100) and 147
tested negative. Blinded details of all clinical samples tested,Fig. 1. Effect of increasing concentration of S. equi DNA in the triplex qPCR reaction.
Dilution series of Se4047 genomic DNA in the presence of 2000 copies of SZIC
internal control target.including culture, singlex and triplex assay results, are presented
in Supplementary Table 1 (see Appendix A). Copy numbers for eqbE
and SEQ2190 quantiﬁed within the triplex assay correlated well
with each other (Fig. 2A) and generated a Spearman’s Coefﬁcient
of 0.84 (P < 0.001). Mean triplex assay copy numbers also corre-
lated well with the singlex eqbE results (Spearman’s Coefﬁcient
of 0.80, P < 0.001) (Fig. 2B).
Sample 181, recovered from the guttural pouches of a horse in
Dorset, contained SEQ2190 copy numbers of 14,030,667, but did
not amplify eqbE in the triplex or singlex assays. Sample 212, taken
from the guttural pouches of another horse from the same yard in
Dorset, similarly tested negative for eqbE using both assays, but
was positive for SEQ2190 (Fig. 2A and B). These samples were re-
moved from the data set for the purposes of plotting the associated
lines of best ﬁt.
Five clinical samples (2.3%) originally tested negative for the
SZIC control, highlighting a potential failure in the DNA extraction
method. These samples were re-extracted, retested and the eqbE
and SEQ2190 triplex results for two discrepant samples, 194 and
211, then were found to be in agreement with singlex assay results.
The SZIC assay detected a mean of 3994 copies in all reactions
where the amount of S. equi DNA was 610,000 copies (n = 175)
(Fig. 2C). However, the SEQ2190 and eqbE assays signiﬁcantly inter-
fered with the SZIC assay when the amount of S. equi DNA exceeded
10,000 copies per reaction (P = 0.0038), leading to a mean of 940
copies of SZIC in these clinical samples (n = 38) and a non-linear
line of best ﬁt (Fig. 2C).
To identify the optimal assay breakpoints and so ensure that the
most robust diagnosis was obtained, triplex data were compared
with the singlex qPCR assay as the gold-standard using STATA.
Optimal sensitivity (90.9%) and speciﬁcity (96.6%) for the eqbE
component of the triplex assay were achieved with a breakpoint
of 110 copies, generating an area under the ROC curve of 0.95,
where a value of 1.0 indicates complete concordance of data. Opti-
mal sensitivity for the SEQ2190 component of the triplex assay
(sensitivity 92.4%, speciﬁcity 97.3%) was achieved with a break-
point of 150 copies, generating an area under the ROC curve of
0.9727.
Using these breakpoints and combining the results of the eqbE
and SEQ2190 assays, so that a sample was reported as positive if
either assay reached its cut-off, 67 positive samples were identi-
ﬁed, of which ﬁve were negative by the singlex assay, giving an
overall sensitivity and speciﬁcity for the triplex assay of 93.9%
and 96.6%, respectively.Comparison of qPCR with the culture assay
The culture test identiﬁed no additional positive clinical sam-
ples and had an overall sensitivity of 60.3% and speciﬁcity of
100% relative to the combined qPCR results. Other b-haemolytic
streptococci were present in 15/27 (56%) culture negative, qPCR
positive samples (10 contained S. zooepidemicus and ﬁve contained
S. equisimilis; see Appendix A: Supplementary Table 1). The mean
qPCR copy number of culture positive/qPCR positive samples was
1,388,580 (n = 41). Culture negative, qPCR positive samples that
did not contain other b-haemolytic streptococci had a mean copy
number of 415 (n = 12) and culture negative/qPCR samples that
contained other b-haemolytic streptococci had a mean S. equi
DNA copy number of 170,312 (n = 15).Discussion
Emerging genome sequencing data and an extensive collection
of S. equi and S. zooepidemicus isolates were exploited to select
two conserved S. equi-speciﬁc targets that are located in separate
A B
C
Fig. 2. (A) Relationship of log10 qPCR copy numbers for eqbE and SEQ2190 within the triplex assay. The location of the results for samples 181 and 212 are highlighted. (B)
Log10 mean quantity of S. equi DNA detected in the triplex assay compared with eqbE quantiﬁed by the singlex assay. The location of the results for samples 181 and 212 are
highlighted. (C) Effect of increasing quantities of S. equi in clinical samples on log10 SZIC copy number. A copy number of one was added to all data, which was then
transformed into a logarithmic format for presentation purposes. The line of best ﬁt and its equation is shown on each graph.
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equibactin locus, which encodes a non-ribosomal peptide synthe-
sis system that enhances the ability of S. equi to acquire iron
(Heather et al., 2008). SEQ2190 encodes a putative sortase-pro-
cessed protein, which was conserved in all strains of S. equi exam-
ined. Targeting both eqbE and SEQ2190 is predicted to signiﬁcantly
reduce the likelihood that both diagnostic targets are lost in a
strain, resulting in the failure of the test and subsequent clonal
expansion of the modiﬁed strain.
This risk and the usefulness of the triplex assay are highlighted
in samples 181 and 212, which tested negative for eqbE, but posi-
tive for the SEQ2190 gene. Decay of the SeM gene in isolates recov-
ered from the guttural pouch has been reported previously
(Chanter et al., 2000). Recently, we identiﬁed signiﬁcant decay of
the S. equi genome on sequencing >230 isolates using the Illumina
HiSeq platform (data not shown), which suggests that reliance on
only one diagnostic target is likely to lead to the reporting of false
negative results.
The novel internal control strain, Sz07770c, which serves as a
DNA extraction and assay control, ensures that all clinical samples
should generate a qPCR result. High levels of S. equi DNA (>10,000copies) out-compete the SZIC assay and generate eqbE positive/
SEQ2190 positive/SZIC negative results. Similarly, high levels of
Bacillus anthracis, Francisella tularensis and Yersinia pestis inhibited
the detection of a Bacillus thuringensis internal control in a multi-
plex qPCR assay (Janse et al., 2010). The triplex qPCR assay was
optimised to ensure that ampliﬁcation of low concentrations of S.
equi DNA (<1000 copies) was not inhibited by the presence of SZIC.
The close agreement between the singlex and triplex assays in this
study (95.8%) and low limit of detection (10–20 copies of S. equi
DNA) suggests that no compromise on sensitivity was made
through inclusion of the SZIC control.
The inclusion of the SZIC assay permits robust quality control of
all assay stages for each clinical sample. Five clinical samples ana-
lysed using the triplex assay failed these criteria and were re-
tested, two of which were positive. The ﬁve discrepant clinical
samples that tested negative on singlex, but positive on triplex,
similarly may be due to assay failures that would have gone unno-
ticed using the singlex assay system. Therefore, the triplex assay
will reduce the number of false negative results and so enable
the detection, isolation and treatment of infected horses before
they can transmit S. equi to others. Since the triplex assay requires
304 K. Webb et al. / The Veterinary Journal 195 (2013) 300–304only the addition of primers and probes speciﬁc to SEQ2190 and
SZIC, the extra cost per sample is £0.16,2 which enables the imple-
mentation of the triplex assay without additional cost to clients.
Comparison of results from the singlex and triplex qPCR assays
with the culture assay highlighted a lack of sensitivity of the cul-
ture assay (60.3%). The lowest mean quantity of S. equi DNA in a
culture positive sample was 960 copies. The presence of other
b-haemolytic streptococci accounted for more than half (15/27)
of culture negative, qPCR positive samples, emphasising the prob-
lem of isolating S. equi from mixed cultures. Our data demonstrate
that the S. equi culture test can no longer be considered the to be
gold-standard test for this organism.
Conclusions
The use of sensitive qPCR assays will improve the identiﬁcation
and treatment of horses infected with S. equi, particularly carriers
where intermittent low level shedding of this bacterium is com-
mon and can be missed by traditional culture and PCR assays.
The strangles triplex assay provides a rapid, sensitive and robust
method for the detection of S. equi infection for minimal additional
cost.
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Appendix A. Supplementary material
Supplementary data associated with this article, which provides
blinded details of all clinical samples used in this study including
culture, singlex and triplex assay results can be found, in the online
version, at http://dx.doi.org/10.1016/j.tvjl.2012.07.007.
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